Battlab. Veterinary Diagnostics from Disease to Optimal Health

Small Animal Gastroenterology

Permeability Test for Small Intestinal Disease

Applications of intestinal permeability testing

Assessment of intestinal permeability is a very sensitive, non-invasive technique to detect and manage small intestinal disease in dogs. This is a simple procedure involving oral administration of a sugar solution containing lactulose and rhamnose, and analysis of a single blood sample taken 2 hours later.

Diagram depicting the procedure for the assessment of intestinal damage using intestinal permeability testing

The results can:

  • identify small intestine as cause of clinical signs – chronic weight loss and/or diarrhoea
  • provide an indication for small intestinal biopsy
  • help determine the cause of intestinal damage eg dietary sensitivity
  • provide objective monitoring of treatment eg bacterial overgrowth

Principles of intestinal permeability testing

The normal small intestine is lined by finger-like villi covered by absorptive epithelial cells which form an effective barrier between the lumen and the lamina propria.
There are two potential routes for passive transfer of molecules across this barrier:

  • PARACELLULAR permeability between epithelial cells is normally low as tight junctions form effective seals to keep out larger harmful molecules
  • TRANSCELLULAR permeability through epithelial cells is normally high as this route allows absorption of small nutrients

Diagram depicting the mechanism of absorption of Lactulose and Rhamnose in the permeability test

High lactulose to rhamnose ratio in blood after oral dosing of these sugars is indicative of small intestinal disease which can cause:

  • increased PARACELLULAR permeability to LACTULOSE due to damage to tight junctions
  • decreased TRANSCELLULAR permeability to RHAMNOSE due to loss of microvilli or villi resulting in reduced surface area

Permeability testing can be more helpful than intestinal biopsy alone in the detection and management of intestinal disease. Pathological changes in biopsies may be non-specific, giving no indication of cause (eg “inflammatory bowel disease” could be due to dietary sensitivity, bacterial overgrowth or may be idiopathic), or biopsy findings may appear normal despite damage (eg bacterial overgrowth).

Detection of dietary sensitivity

Application of permeability testing to identify dietary sensitivity as the cause of intestinal damage is illustrated in the figure below. This shows test results in a 3 year-old Golden retriever with chronic vomiting and diarrhoea. High permeability pre-treatment indicated intestinal damage which resolved on a chicken and rice exclusion diet with relapse on dietary challenge, indicating true dietary sensitivity.

Diagram showing high permeability in a dog with dietary sensitivity which improves with treatment and relapsed with challenge

Management of small intestinal bacterial overgrowth

Permeability testing has proved particularly useful to assess the severity of mucosal damage in small intestinal bacterial overgrowth (SIBO) – also known as “antibiotic-responsive enteropathy) - and to help long-term management.

Intestinal permeability has been shown to be increased in approximately 50% of clinical cases with SIBO, even when there are no histological abnormalities. Normalization of intestinal permeability following 4 weeks of antibiotic therapy indicates successful repair of mucosal damage.

Diagram depicting use of permeability testing to determine repair of intestine following treatment of bacterial overgrowth

This figure shows that dogs with high permeability after 4 weeks antibiotic therapy are 3 times more likely to relapse despite an apparent clinical response to treatment, and continuation of antibiotic therapy is therefore recommended. Differences are more marked after 3 months of treatment as dogs with high permeability are approximately 8 times more likely to relapse. A persistent high permeability in dogs with a poor clinical response should prompt further investigation of underlying disease, such as “inflammatory bowel disease” or neoplasia.

Batt Laboratories Ltd, University of Warwick Science Park, The Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ
Tel: 0247 632 3275. Fax: 0871 750 5323. Email: admin@battlab.com. © Battlab 2010. All rights reserved.